Details of the Drug

General Information of Drug (ID: DMDZ7S0)

• Drug Name: Myolimus

Indication

Disease Entry	ICD 11	Status	REF
Coronary artery disease	BA80	Phase 1	[1]

• Cross-matching ID: TTD ID: D0E8AE

References

• [1] ClinicalTrials.gov (NCT02086006) Elixir Medical Clinical Evaluation of the DESolve Myolimus Eluting Bioresorbable Coronary Stent System - DESolve I Trial. U.S. National Institutes of Health.